Reviewed by Jose Lucar, MD, The George Washington University In this retrospective cohort study conducted in four Canadian adult medicine wards between 2010-2019, the authors…
Reviewed by David and Cindy Fernandez-Pittol and colleagues conducted a multicenter, prospective analysis from January 2021 to June 2022, using a lateral flow immunoassay “BL-DetecTool”…
Reviewed by Sara Karaba, MD, PhD, MHS, Johns Hopkins University and Jen Cihlar, DO, Vanderbilt University Medical Center Antibiotics and proton pump inhibitors (PPI) are…
C-D-I wonder what’s new with our old friend Use of Molecular Testing: “From Bench to Bedside” Maximizing resources in stewardship: Look at the quartiles Using…
Reviewed by Barry Rittmann, MD, MPH, Virginia Commonwealth University A recent article from the British Medical Journal assessed the effectiveness in standardized and manualized interventions…
Reviewed by Sara Karaba, MD, PhD, MHS, Johns Hopkins University The SABATO trial is an open-label, randomized, controlled, non-inferiority trial comparing IV vs early oral…
Reviewed by Sara Karaba, MD, PhD, MHS, Johns Hopkins University In a multicenter, retrospective, propensity-score weighted cohort of patients with carbapenem-resistant Enterobacterales (CRE) bacteremia there…
Reviewed by Jen Cihlar, DO, Vanderbilt University Medical Center This systematic review comprising of 41 relevant studies looking at antibiotic prescribing habits for acute infections…
Reviewed by David Cluck, PharmD, University of Virginia and Cindy Noyes, MD, University of Vermont Medical Center Using causal inference methods, Alzaidi and colleagues describe…
Oral antimicrobial therapy for Gram-negative bacteremia: Have We Hit the “Target”? Early career general practitioner prescribing habits – the kids are alright! No Need to…
Reviewed by Erica Stohs, MD, MPH, University of Nebraska Retrospective analysis of 20 years’ worth of Veterans Health Administration (VHA) hospitals’ antibiograms for E. coli…
Reviewed by Dr. Michael Payne, Providence Health Care The WHO recommends an all oral bedaquiline based second line regimen for treatment of drug resistant (DR)…